NCT00376779View on ClinicalTrials.gov

Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age

PHASE2CompletedINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Acellular PertussisTetanusDiphtheriaHepatitis BPoliomyelitisHaemophilus Influenzae Type b
Interventions
BIOLOGICAL

Infanrix hexa Vaccine

Trial Locations (6)

20520

GSK Investigational Site, Turku

28120

GSK Investigational Site, Pori

33100

GSK Investigational Site, Tampere

90100

GSK Investigational Site, Oulu

04400

GSK Investigational Site, Järvenpää

01300

GSK Investigational Site, Vantaa

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY